Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer risk management decision making for BRCA+ women.

Western journal of nursing research - 1 Jan 2015

Leonarczyk Terri Jabaley, Mawn Barbara E

Abstract excerpt

Women with pathogenic BRCA genetic mutations face high risks for cancer development. Estimates vary among mutation carriers, with lifetime risks ranging from 41% to 90% for breast cancer and 8% to 62% for ovarian cancer. Cancer risk management options for BRCA mutation positive (BRCA+) women have life-altering implications. This qualitative, phenomenological study explored the experience of cancer risk management...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Decision Making
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Ovarian Neoplasms

Share to Qualitative Research

Share to Risk Management

Source

Identifiers

PMID: 24470135
DOI: 10.1177/0193945913519870

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer risk management decision making for BRCA+ women.PMID 24470135Read ↗

Involvement and Influence of Healthcare Providers, Family Members, and Other Mutation Carriers in the Cancer Risk Management Decision-Making Process of BRCA1 and BRCA2 Mutation Carriers.Semantic proximity Read ↗

Seeking balance: decision support needs of women without cancer and a deleterious BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Learning about a twist in the road: perspectives of at-risk relatives learning of potential for cancer.Semantic proximity Read ↗

Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer.Semantic proximity Read ↗

"When information is not enough": A model for understanding BRCA-positive previvors' information needs regarding hereditary breast and ovarian cancer risk.Semantic proximity Read ↗

"It's not if I get cancer, it's when I get cancer": BRCA-positive patients' (un)certain health experiences regarding hereditary breast and ovarian cancer risk.Semantic proximity Read ↗

Information needs of women with BRCA mutations regarding cancer risk management and decision-making.Semantic proximity Read ↗

Perceptions and care Recommendations from Previvors: Qualitative analysis of female BRCA1/2 mutation Carriers’ experience with genetic testing and counselingSemantic proximity Read ↗

In their own words: treating very young BRCA1/2 mutation-positive women with care and caution.Semantic proximity Read ↗

Helping Patients Understand and Cope with BRCA Mutations.Semantic proximity Read ↗

Preserving the self: the process of decision making about hereditary breast cancer and ovarian cancer risk reduction.Semantic proximity Read ↗

Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.